Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: New Appointments at Cue Health, Berkeley Lights, LGC, More

Cue Health: David Arida 

Diagnostic testing firm Cue Health has appointed David Arida as chief operating officer. Arida joins Cue from Dexcom, a diabetes care technology company, where he served in multiple senior operational roles since 2011, most recently as senior vice president of global manufacturing operations. Prior to Dexcom, Arida held a number of management, consulting, or engineering positions at Alere (now Abbott), Amylin Pharmaceuticals (now AstraZeneca), and PRTM (now PWC).

Berkeley Lights: Siddhartha Kadia 

Berkeley Lights has appointed Siddhartha Kadia to its board of directors, increasing the board's size to nine members. Kadia was president and CEO of EAG Laboratories, a company acquired by Eurofins Scientific in 2017, and, before that, president of life sciences at Life Technologies. He also serves on the boards of IsoPlexis and BioSkryb. Kadia holds a PhD in biomedical engineering from Johns Hopkins University.

LGC: Euan O'Sullivan 

Euan O'Sullivan has been appointed CEO of international life sciences measurement and testing company LGC, effective immediately.  

O'Sullivan, previously LGC's president and chief operating officer, succeeds Tim Robinson, who served as CEO from May 2013. Robinson will now become chairman of the group. O'Sullivan joined LGC in 2007 as non-executive director, taking over as corporate development director in 2010. He was later appointed managing director of the Standards division and joined the board as executive director in 2017.

For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.